Brind.

Kailera Therapeutics and Hengrui announced a multi-billion-dollar partnership, while Merck seeks pipeline assets to offset revenue decline.

1 report, 1 independent Updated Aug 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Kailera Therapeutics and Hengrui announced a multi-billion-dollar partnership, while Merck seeks pipeline assets to offset revenue decline.

Who's involved

What this event is mainly about
MerckHengrui

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped